Moreover, she is the PI of four national key research projects funded by Chinese government, including China Patient-centered Evaluative Assessment of Cardiac Events (China PEACE) (2012 2014), The Study on Hereditary Susceptibility to Statin-related Myopathy (2011 2015), Establishment of the Bio-bank of Chinese Cardiovascular & Cerebro- vascular Disease (2011 2015), and China PEACE-stent (2013 2014). Dr. Jiang started her international collaboration with the Oxford University in the 1980 s and since then she has been cooperating with different top research institu- tions worldwide. Presently, her collaborative partners include Oxford University, Yale University, NHLBI, NIH, University of Edinburgh, Duke University, Merck Research Laboratories, etc. Through years of research operation, Dr. Jiang has set up a reliable and stable national coopera- tion network of over 200 hospitals within 31 provinces in China. Her achievements in the field of evidence-based medicine have attracted international recognition and acclaim. Sir Richard Peto, Co-Director of Clinical Trials Service Unit and Epidemiological Studies Unit at Oxford University, once said that she has been a whirlwind force for evidence and The Lancet commented that she is at the heart of China s evidence base. Dr Jiang reported no relevant financial relationships Florian Kronenberg, MD, received his MD from the University of Innsbruck, Austria. After specializing in Medical Genetics he worked two years each at the University of Utah, Salt Lake City, USA and the Institute of Epidemiology at the Helmholtz Center, Munich, Germany. In 2004, he became Full Professor for Genetic Epidemiology at the Innsbruck Medical University where he presently heads the Department of Medical Genetics, Molecular and Clinical Pharmacology. Dr. Kronenberg served as PI in several studies on genetic risk factors for atherosclerosis and biomarkers for the progression of CKD including the Mild to Moderate Kidney Disease Study00 (MMKD). 